ResearcherNational Hospital Organization Kyushu Cancer CenterActive in the last 2 years
Lingaku Lee
Matched on ORCID iD 0000-0003-1005-5606; OpenAlex author ID A5041040977. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 3 papers
Papers 7
- Symptom presentation at diagnosis as a biological risk indicator in both resectable and unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-026-03369-y↗
- Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis. Co-author DOI 10.1200/po-25-01104↗
- Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers18132120↗
- Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of a… First author DOI 10.1111/ajco.13669↗
- Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic… Co-author DOI 10.3390/jcm11175084↗
- [Lifestyle and the risk of pancreatic cancer]. Co-author PMID 25857060↗
- Giardiasis in the pancreas accompanied by pancreatic cancer. First author DOI 10.1097/mpa.0b013e3181f6a1b9↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masayuki Furukawa · 5 shared papers, 2011–2026 · strength 1.02
- Paper Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. DOI 10.3390/cancers18132120↗
- Paper Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreat… DOI 10.1200/po-25-01104↗
- Paper Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse… DOI 10.1111/ajco.13669↗
- Masami Miki · 3 shared papers, 2022–2026 · strength 0.70
- Paper Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. DOI 10.3390/cancers18132120↗
- Paper Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse… DOI 10.1111/ajco.13669↗
- Paper Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Ther… DOI 10.3390/jcm11175084↗
- Takahiro Tomino · 1 shared paper, 2026 · strength 0.26
- Keishi Sugimachi · 1 shared paper, 2026 · strength 0.26
- Masaru Morita · 1 shared paper, 2026 · strength 0.26
- Masatoshi Murakami · 1 shared paper, 2022 · strength 0.14
- Nao Fujimori · 1 shared paper, 2022 · strength 0.14
- Yoshihiro Ogawa · 1 shared paper, 2022 · strength 0.14
- Tetsuhide Ito · 1 shared paper, 2015 · strength 0.06
- Hisato Igarashi · 1 shared paper, 2015 · strength 0.06
- Toru Ikegami · 1 shared paper, 2011 · strength 0.03
- Akihiro Funakoshi · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.